ePrints

Acetylcholinesterase inhibitors in treatment resistant psychotic depression

Lookup NU author(s): Dr Chris Smart, Professor Hamish McAllister-WilliamsORCiD, Dr David Cousins

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Dopamine receptor antagonists can be effective in psychotic depression but response is not assured. Visual hallucinations may arise from a dysregulation of brain cholinergic systems and acetylcholinesterase inhibitors (AChEIs) can treat such hallucinations in dementia with Lewy bodies (DLB). AChEIs have been used in schizophrenia with some success but their efficacy and tolerability in psychotic depression is unclear. This striking case illustrates AChEIs specifically targeting multimodal hallucinations in treatment-resistant depression. To our knowledge it is the first case report to do so. It highlights the value of delineating psychopathology when considering novel interventions. This case also shows the idiosyncratic nature of side effects and the importance of pursuing different drugs within class.

Publication metadata

Author(s): Smart C, McAllister-Williams RH, Cousins DA

Publication type: Article

Publication status: Published

Journal: Therapeutic Advances in Psychopharmacology

Year: 2018

Volume: 8

Issue: 1

Pages: 59-61

Print publication date: 01/01/2018

Online publication date: 10/07/2018

Acceptance date: 08/06/2017

ISSN (print): 2045-1253

ISSN (electronic): 2045-1261

Publisher: Sage Publications Ltd

URL: https://doi.org/10.1177/2045125317718810

DOI: 10.1177/2045125317718810

Altmetrics

Share